Bilibili Inc. (NASDAQ: BILI): BofA Securities raised its Neutral rating to Buy with a $28 target price. The consensus target is $27.30. Monday’s $21.10 close was up almost 7% for the day on the upgrade.
Bill Holdings Inc. (NYSE: BILL): Jefferies reiterated a Buy rating with a $125 target price. The consensus target is higher at $139.86, but the stock closed on Monday at $73.82. That was up 8% on the day, after the company’s exposure to bank issues in California were seen as not a problem.
Cabot Corp. (NYSE: CBT): Credit Suisse initiated coverage with an Outperform rating and a $94 target price. The consensus target is $92.80, and the stock closed on Monday at $73.59.
Coinbase Global Inc. (NASDAQ: COIN): Though Oppenheimer maintained an Outperform rating, the firm lowered its $84 target price to $70. The shares traded near $185 a year ago but closed most recently at $59.17. That was a one-day gain of 11% due to the surge in Bitcoin on Monday.
Eli Lilly and Co. (NYSE: LLY): When Wells Fargo lifted its Equal Weight rating to Overweight, it also raised its $360 target price to $375. The consensus target is $380.13. The shares closed up 3% on Monday at $324.49.
GE Healthcare Technologies Inc. (NASDAQ: GEHC): Evercore ISI initiated coverage with an Outperform rating and a $90 target price, the same as the consensus target. The shares finished Monday at $76.24.
Genius Sports Ltd. (NASDAQ: GENI): Oppenheimer maintained an Outperform rating with a $7 target price. The consensus target is $7.50, and the shares closed on Monday at $4.24.
Hercules Capital Inc. (NYSE: HTGC): Keefe Bruyette’s downgrade to Underperform from Market Perform included a target price cut to $10.50 from $14.50. The consensus target is $16.22 for now. Monday’s close at $11.56 was down 6% for the day on the downgrade and capital concerns.
Intuit Inc. (NASDAQ: INTU): Oppenheimer reiterated an Outperform. Its $476 price target is less than the $483.95 consensus target. Monday’s closing print was $391.56.
JPMorgan Chase & Co. (NYSE: JPM): Wells Fargo upgraded the shares to Overweight from Equal Weight. Its $148 target price increased to $155, but that is still less than the $158.37 consensus target. The stock closed on Monday at $131.25.
Merck & Co. Inc. (NYSE: MRK): The Overweight rating at Wells Fargo was cut to Equal Weight, and the $120 target price dropped to $115. That compares with a $119.75 target and Monday’s $105.73 closing share price.
Moderna Inc. (NASDAQ: MRNA): TD Cowen’s upgrade to Outperform from Market Perform came with a target price hike to $180 from $150. The consensus target is up at $224.50. The stock closed 7% higher on Monday at $147.90.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
